Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS)
Clinical trial NCT05113888 · UNKNOWN
Trial details
- NCT number
- NCT05113888
- Sponsor
- China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-08-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.